12 results

• GLP-1 Dementia, Alzheimer’s Disease Risks Questioned in New Study

  April 27, 2026

  Irvin Jackson

  A new study finds cognitive decline in patients taking GLP-1 medications for longer than 10 years, yet researchers say it may be the result of those patients living longer than their peers.

• Gastrointestinal Problems Are Most Common GLP-1 Side Effects, Study Finds

  April 6, 2026

  Irvin Jackson

  A new study links GLP-1 medications to increased gastrointestinal risks, while also raising broader concerns about other potential complications associated with the diabetes and weight loss drugs.

• Wegovy Vision Loss Risks 5 Times Higher Than Ozempic: Study

  March 13, 2026

  Irvin Jackson

  A new study links higher doses of semaglutide, the active ingredient in Ozempic and Wegovy, with increased vision loss risks, with Wegovy carrying five times the risk than Ozempic.

• GLP-1 Gout and Bone Fracture Risks Highlighted in New Studies

  March 10, 2026

  Irvin Jackson

  Two new studies warn that Ozempic, Mounjaro and similar drugs may be linked to increased risks of bone density loss, osteoporosis and gout, particularly in older patients.

• Study Finds No Link Between Side Effects of GLP-1s and Thyroid Cancer

  February 24, 2026

  Irvin Jackson

  A new report dismisses concerns linking drugs like Ozempic and Mounjaro to increased thyroid cancer risks, despite the drugs carrying a black box warning from the FDA.

• Ozempic, Wegovy NAION Risks Twofold Higher Compared to SGLT2i Drugs: Study

  February 19, 2026

  Irvin Jackson

  Researchers from Veterans' Affairs say that drugs like Ozempic and Wegovy carry double the risk of vision problems than other types of diabetes medications.

• Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects

  November 26, 2025

  Russell Maas

  An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.

• Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators

  June 9, 2025

  Irvin Jackson

  European regulators have determined that Ozempic and similar semaglutide-based drugs increase the risk of a rare vision disorder that can cause vision loss and blindness.

• Stomach Paralysis Lawsuit Filed Over Side Effects of Ozempic, Trulicity, Rybelsus

  February 26, 2025

  Irvin Jackson

  A lawsuit claims the side effects of Ozempic, Trulicity and Rybelsus caused a woman to develop severe stomach paralysis, which led to the need for medical treatment.

• Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL

  November 15, 2024

  Irvin Jackson

  Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.